Claire Reiss, a major owner of Biocept, recently acquired 227,272 shares of the company. The buys took place at $1.10 per share, on October 19, 2016. Reiss now owns 1,051,285 shares of the company. Reiss operates out of San Diego, CA. Some additional info was provided as follows:

Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 1,638,675 fewer shares. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 9,340 fewer shares.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Biocept makes a similar move, sign up!

Other recent filings from the company include the following:

On February - Feb. 12, 2018
Sabby Healthcare Master Fund, Ltd. just issued a filing suggesting it has sold all of its Biocept - Feb. 1, 2018
On January - Jan. 30, 2018
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Jan. 26, 2018
Registration adding securities to prior Form S-1 registration [Rule 462(b)] - Jan. 26, 2018

Auto Refresh

Feedback